❭ Research by medical division ❭ Cancer Medicine ❭ Institute for Cancer Research ❭ Dept. of Tumor Biology ❭ News

News

Scroll to top

Home Institute for Cancer Research Dept. of Tumor Biology

  • Resources and expertise
  • Cancer Systems Biomedicine [Clancy)
  • Translational Cancer Therapy [Flatmark]
  • Metastasis Biology and Experimental Therapeutics [Mælandsmo]
  • Molecular Biology of Sarcomas [Wesche]
  • Project groups Tumor Biology
  • Publications
  • Staff
  • Vacant positions
  • News

Recent publications

Kostas M, Munthe E, Haugsten EM, Mateus D, Sørensen V, Laerdahl JK, Szybowska P, Wiedlocha A, Lecaudey LA, Nakken S, Schink KO, Stenmark H, Wesche J (2026)
Unconventional activation of the proto-oncogene FGFR1 by extracellular phosphate via H2O2-mediated kinase oxidation
Cell Rep, 45 (6), 117504 (in press)
DOI 10.1016/j.celrep.2026.117504, PubMed 42247296

Ree AH, Meltzer S, Flatmark K, Dueland S (2026)
Low-intensity induction chemotherapy before chemoradiotherapy for rectal cancer: 10-year overall survival in the LARC-RRP trial
Br J Radiol (in press)
DOI 10.1093/bjr/tqag133, PubMed 42233285

Nunes-Xavier CE, Rodríguez-Ramos A, Pulido R (2026)
β-catenin at the crossroads of cancer and neurodevelopment
Trends Cancer (in press)
DOI 10.1016/j.trecan.2026.05.001, PubMed 42215419

More publications

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Cookie policy

Accessibility statement (in Norwegian)